An Experimental Evaluation of Pantopaque and Other Recently Developed Myelographic Contrast Media

Robert L. Fisher

Radiology · 1965 · 40 citations · 0 references

Concepts

Abstract

SINCE the original radiographic visualization of the spinal cord in 1919 (6), many different myelographic contrast media have been employed. Unfortunately, none has fulfilled all the requirements of an ideal contrast medium—no toxicity, complete and rapid absorption, good radiographic contrast, and miscibility with the cerebrospinal fluid (3, 8). Of the materials currently used, ethyl iodophenyl-undecylate (Pantopaque) has radiographic shortcomings and has been associated with significant toxicity—intravasation, adhesive arachnoiditis, severe meningeal reaction, and death—as recently summarized by Di Chiro and Fisher (8). Toxic reactions have also been reported from the water-soluble compound, methiodal (Abrodil, Skiodan), which requires the administration of a spinal anesthesia and has thus been employed clinically only in examination of the lumbosacral area (9, 14–17, 22). Gas myelography has found only limited use because of the considerable skill required for its performance and interpretation, the faintness of the gas contrast, and its discomfort to the patient (8). The search for a more satisfactory contrast medium has recently led to the investigation of three agents—SH 617L (Myelographin) (25), Ethiodol emulsion (24), and meglumine iothalamate (Conray) (4, 5). Original reports would indicate that, though these agents differ considerably in their chemical composition, they have been claimed to possess a low toxicity, excellent radiographic contrast, and fairly rapid absorption from the subarachnoid space (Table I). The present work is an attempt to compare the radiographic and toxicologic properties of these new contrast agents in animals. Material and Methods Thirty cats weighing 1.6–5.0 kg were divided into five groups to receive subarachnoidal injections of saline (controls), Pantopaque, SH 617L (20 per cent suspension in 5 per cent dextrose solution),2 Ethiodol emulsion,3 and Conray (60 percent).4 Partial laminectomies at the lower lumbar spinal level were performed under sterile operating-room conditions with the animals under light Nembutal anesthesia. Injections were then made directly into the subarachnoid space. In each group, 2 animals were to be sacrificed at one week, one month, and three months following injection. A dosage of 0.5 ml/kg of each material was used in the “one week” animals while 0.25 ml/kg was employed in the remainder. Postero-anterior and lateral spine roentgenograms were obtained immediately after injection and just prior to sacrifice. Complete autopsies were performed in animals which died during the course of the experiment. In all cats the spinal cord and meninges were examined grossly and microscopically at cervical, thoracic, and lumbar levels. In addition, one cat was given a subarachnoidal injection of 20 per cent methiodal (0.5 ml/kg) and sacrificed one week later. Results